Browse by Sector

Explore NASDAQ stocks by their primary economic sector.

All NASDAQ Stocks Healthcare 892 Financials 884 Information Technology 517 Industrials 386 Consumer Discretionary 320 Communication Services 200 Consumer Staples 114 Materials 78 Energy 67 Real Estate 64 Utilities 27

Industries in Healthcare

Refine the list using the company’s more specific operating industry.

Biotechnology 471 Pharmaceuticals 159 Healthcare Equipment & Supplies 138 Healthcare Providers & Services 61 Life Sciences Tools & Services 38 Health Care Technology 25
Industry stocks

Biotechnology Stocks on NASDAQ

Compare NASDAQ-listed Biotechnology stocks by fair value, valuation, financial quality, profitability, risk, and market outlook.

INmune Bio Inc (INMB)
Fair Value23.7% Upside Undervalued Analyst493.2% Upside Market Cap36.136 M P/E— Yield0.0% HealthWeak
  NASDAQ
Innate Pharma SA (IPHA)
Fair Value11.4% Upside Fair Analyst376.2% Upside Market Cap131.7 M P/E— Yield0.0% HealthWeak
  NASDAQ
Instil Bio Inc (TIL)
Fair Value30.5% Upside Undervalued Analyst0.1% Upside Market Cap47.406 M P/E— Yield0.0% HealthGood
  NASDAQ
Inventiva Sa (IVA)
Fair Value-30.1% Downside Overvalued Analyst318.7% Upside Market Cap890.9 M P/E— Yield0.0% HealthWeak
  NASDAQ
Invivyd Inc (IVVD)
Fair Value20.3% Upside Undervalued Market Cap172.4 M P/E— Yield0.0% HealthGood
  NASDAQ
Jade Biosciences Inc (JBIO)
Fair Value-7.7% Downside Fair Analyst255.5% Upside Market Cap896.7 M P/E— Yield0.0% HealthGood
  NASDAQ
Janux Therapeutics Inc (JANX)
Fair Value28.5% Upside Undervalued Analyst99.7% Upside Market Cap981.9 M P/E— Yield0.0% HealthGood
  NASDAQ
Jasper Therapeutics Inc (JSPR)
Market Cap15.612 M P/E— Yield0.0% HealthWeak
  NASDAQ
Kalaris Therapeutics Inc (KLRS)
Fair Value2.4% Upside Fair Analyst648.6% Upside Market Cap56.18 M P/E— Yield0.0% HealthWeak
  NASDAQ
Keros Therapeutics Inc (KROS)
Fair Value53.5% Upside Bargain Analyst109.9% Upside Market Cap187.4 M P/E— Yield0.0% HealthFair
  NASDAQ
Kodiak Sciences Inc (KOD)
Fair Value-36.9% Downside Overvalued Analyst33.7% Upside Market Cap5.709 B P/E— Yield0.0% HealthFair
  NASDAQ
Korro Bio Inc (KRRO)
Fair Value-11.7% Downside Fair Analyst37.1% Upside Market Cap216.9 M P/E— Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Momentum
Kymera Therapeutics Inc (KYMR)
Fair Value-27.8% Downside Overvalued Analyst12.8% Upside Market Cap10.938 B P/E— Yield0.0% HealthFair
  NASDAQ
Lantern Pharma Inc (LTRN)
Fair Value40.2% Upside Undervalued Market Cap6.801 M P/E— Yield0.0% HealthWeak
  NASDAQ
Legend Biotech Corp (LEGN)
Fair Value30.1% Upside Undervalued Analyst102.4% Upside Market Cap4.368 B P/E— Yield0.0% HealthGood
  NASDAQ
Liminatus Pharma Inc (LIMN)
Fair Value-46.4% Downside Overvalued Market Cap3.533 M P/E— Yield0.0% HealthWeak
  NASDAQ
Longeveron LLC (LGVN)
Fair Value56.1% Upside Bargain Market Cap5.452 M P/E— Yield0.0% HealthWeak
  NASDAQ
Lyell Immunopharma Inc (LYEL)
Fair Value-18.6% Downside Overvalued Analyst152.5% Upside Market Cap367.6 M P/E— Yield0.0% HealthFair
  NASDAQ
MeiraGTx Holdings PLC (MGTX)
Fair Value23.6% Upside Undervalued Analyst226.1% Upside Market Cap817.3 M P/E10.3x Yield0.0% HealthGreat
  NASDAQ Featured in High-Growth Small-Cap Stocks
Mirum Pharmaceuticals Inc (MIRM)
Fair Value-12.5% Downside Fair Analyst64.0% Upside Market Cap6.106 B P/E— Yield0.0% HealthFair
  NASDAQ
Moderna Inc (MRNA)
Fair Value-39.9% Downside Overvalued Analyst-42.7% Downside Market Cap96.399 B P/E— Yield0.0% HealthGood
  NASDAQ Featured in Top Overvalued Stocks High-Momentum Stocks
Molecular Partners AG ADR (MOLN)
Fair Value-3.4% Downside Fair Analyst219.0% Upside Market Cap122.9 M P/E— Yield0.0% HealthWeak
  NASDAQ
Monopar Therapeutics Inc (MNPR)
Fair Value-12.6% Downside Fair Analyst93.3% Upside Market Cap451.2 M P/E— Yield0.0% HealthGood
  NASDAQ
Monte Rosa Therapeutics Inc (GLUE)
Fair Value-11.5% Downside Fair Analyst162.2% Upside Market Cap874.5 M P/E— Yield0.0% HealthGood
  NASDAQ
MoonLake Immunotherapeutics (MLTX)
Fair Value27.5% Upside Undervalued Analyst164.2% Upside Market Cap919.2 M P/E— Yield0.0% HealthWeak
  NASDAQ
Nanobiotix (NBTX)
Fair Value-30.3% Downside Overvalued Analyst81.6% Upside Market Cap1.556 B P/E— Yield0.0% HealthFair
  NASDAQ
NewAmsterdam Pharma Company NV (NAMS)
Fair Value-5.1% Downside Fair Analyst164.9% Upside Market Cap2.258 B P/E— Yield0.0% HealthFair
  NASDAQ
NewcelX AG (NCEL)
Fair Value-12.6% Downside Fair Analyst695.8% Upside Market Cap16.693 M P/E— Yield0.0% HealthFair
  NASDAQ
NextCure Inc (NXTC)
Fair Value8.9% Upside Fair Analyst290.6% Upside Market Cap23.436 M P/E— Yield0.0% HealthFair
  NASDAQ
Nkarta Inc (NKTX)
Fair Value53.1% Upside Bargain Analyst568.8% Upside Market Cap112.5 M P/E— Yield0.0% HealthFair
  NASDAQ
Nurix Therapeutics Inc (NRIX)
Fair Value42.1% Upside Undervalued Analyst128.1% Upside Market Cap1.621 B P/E5.5x Yield0.0% HealthGreat
  NASDAQ
Nuvalent Inc (NUVL)
Market Cap9.834 B P/E—
  NASDAQ
Olema Pharmaceuticals Inc (OLMA)
Fair Value9.7% Upside Fair Analyst439.9% Upside Market Cap591.5 M P/E— Yield0.0% HealthFair
  NASDAQ
Onkure Therapeutics Inc (OKUR)
Fair Value44.3% Upside Undervalued Analyst513.9% Upside Market Cap102.3 M P/E— Yield0.0% HealthFair
  NASDAQ
Oric Pharmaceuticals Inc (ORIC)
Fair Value3.6% Upside Fair Analyst155.8% Upside Market Cap880 M P/E— Yield0.0% HealthFair
  NASDAQ
Pasithea Therapeutics Corp (KTTA)
Fair Value-10.6% Downside Fair Analyst476.9% Upside Market Cap17.376 M P/E— Yield0.0% HealthFair
  NASDAQ
Passage Bio Inc (PASG)
Fair Value17.2% Upside Fair Analyst348.0% Upside Market Cap11.134 M P/E— Yield0.0% HealthFair
  NASDAQ
Pharming Group Nv (PHAR)
Fair Value10.7% Upside Fair Analyst185.4% Upside Market Cap880.1 M P/E36.4x Yield0.0% HealthGreat
  NASDAQ
Pmv Pharmaceuticals Inc (PMVP)
Fair Value25.5% Upside Undervalued Analyst213.7% Upside Market Cap96.279 M P/E— Yield0.0% HealthFair
  NASDAQ Featured in Bullish Trend Stocks
Praxis Precision Medicines Inc (PRAX)
Fair Value-15.0% Downside Fair Analyst147.5% Upside Market Cap7.332 B P/E— Yield0.0% HealthFair
  NASDAQ
Precision BioSciences Inc (DTIL)
Fair Value-25.4% Downside Overvalued Analyst197.9% Upside Market Cap275.7 M P/E— Yield0.0% HealthFair
  NASDAQ
Prelude Therapeutics Inc (PRLD)
Fair Value14.2% Upside Fair Analyst158.8% Upside Market Cap366.1 M P/E— Yield0.0% HealthGood
  NASDAQ Featured in Low-Float Small-Cap Momentum Stocks High-Growth Small-Cap Stocks
Propanc Biopharma Inc (PPCB)
Fair Value4.9% Upside Fair Market Cap1.038 M P/E— Yield0.0%
  NASDAQ
Quince Therapeutics Inc (QNCX)
  NASDAQ
Rallybio Corp (RLYB)
Fair Value-7.4% Downside Fair Analyst-49.0% Downside Market Cap84.474 M P/E3.2x Yield0.0% HealthGreat
  NASDAQ
Recursion Pharmaceuticals Inc (RXRX)
Fair Value2.3% Upside Fair Analyst109.0% Upside Market Cap2.182 B P/E— Yield0.0% HealthWeak
  NASDAQ
Relay Therapeutics Inc (RLAY)
Fair Value-15.7% Downside Fair Analyst62.3% Upside Market Cap3.725 B P/E— Yield0.0% HealthFair
  NASDAQ
RenovoRx Inc (RNXT)
Fair Value47.9% Upside Undervalued Analyst498.7% Upside Market Cap53.704 M P/E— Yield0.0% HealthFair
  NASDAQ
Replimune Group Inc (REPL)
Fair Value-41.1% Downside Overvalued Analyst16.6% Upside Market Cap1.898 B P/E— Yield0.0% HealthFair
  NASDAQ
Revolution Medicines Inc (RVMD)
Fair Value2.3% Upside Fair Analyst45.7% Upside Market Cap38.077 B P/E— Yield0.0% HealthWeak
  NASDAQ
Explore listed stocks on NASDAQ with company information and fair value data.